Richard O’Donovan

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

SUBSTITUTION OF ALUMINIUM SALTS BY MAGNESIUM SALTS IN CONTROL OF DIALYSIS HYPERPHOSPHATAEMIA

Richard O’Donovan, Mette Hammer, Dianne Baldwin et al. · The Lancet · 1986 · 93 citations

Medicine, Nephrology, Dialysis +9

Persistent lupus activity in end-stage renal disease

N. Kevin Krane, Khudr Burjak, Michael Archie et al. · American Journal of Kidney Diseases · 1999 · 70 citations

Medicine, Nephrology, Dialysis +12

Preservation of Renal Function by Percutaneous Renal Angioplasty in High-Risk Elderly Patients: Short-Term Outcome

Richard O’Donovan, Oscar H. Gutierrez, Joseph L. Izzo · ˜The œNephron journals/Nephron journals · 2008 · 44 citations

Medicine, Nephrology, Surgery +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17